Skip to main content
Veterinary Medicines

Doxytab vet. Flav. 400 mg Tablets for dogs

Authorised
  • Doxycycline hyclate

Product identification

Medicine name:
Doxytab vet. Flav. 400 mg Tablets for dogs
Doxytab vet. Flav. Compresse da 400 mg per cani
Active substance:
  • Doxycycline hyclate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Doxycycline hyclate
    462.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Aluminium - PVC/PE/PVDC blister.Cardboard box of 1 blisters of 30 tablets.
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 10 blisters of 30 tablets.
  • Aluminium - PVC/PE/PVDC blister.Cardboard box of 3 blisters of 10 tablets.
  • Aluminium - PVC/PE/PVDC blister.Cardboard box of 10 blisters of 10 tablets.
  • Aluminium - PVC/PE/PVDC blister.Cardboard box of 5 blisters of 30 tablets.
  • Aluminium - PVC/PE/PVDC blister.Cardboard box of 5 blisters of 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cp-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105433
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0331/004
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 26/02/2024
Download
Italian (PDF)
Published on: 13/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."